The Future of Glaucoma Treatment Ripasudil

Journal Title: The Egyptian Journal of Hospital Medicine - Year 2017, Vol 68, Issue 2

Abstract

Glaucoma is a leading cause for worldwide blindness and is characterized by progressive optic nerve damage. The etiology of glaucoma is unknown, but elevated intraocular pressure (IOP) and advanced age have been identified as risk factors. IOP reduction is the only known treatment for glaucoma. Recently, drugs that inhibit Rho associated protein kinase (ROCK) have been studied in animals and people for their ability to lower IOP and potentially treat POAG. ROCK inhibitors lower IOP through a trabecular mechanism and may represent a new therapeutic approach for the treatment of glaucoma. Ripasudil is the first Rho-kinase inhibitor ophthalmic solution developed for the treatment of glaucoma and ocular hypertension in Japan 2014. ROCK inhibition not only reduces intraocular pressure (IOP) but also increases ocular blood flow

Authors and Affiliations

Keywords

Related Articles

Patterns of Maxillofacial Fractures Associated with Assault Injury in Khamis Mushait City and Related Factors

Objective: The objective of this study was to explore the patterns of maxillofacial fractures associated with assaults among male patients in Khamis Mushait, Saudi Arabia.

Malignant Breast Tumors: Role of MRI in Predicting Histopathological Grading

Introduction: Magnetic Resonance Imaging (MRI) is an established supplemental technique to mammography and ultrasonography for evaluation of breast lesions. Diffusion-weighted MR imaging (DWI) has recently been integrate...

Comparative Study between Myoring and Ferrara Ring Intracorneal Implantation Using Femtosecond Laser for Treatment of Keratoconus

Background: Keratoconus is a bilateral progressive, non-inflammatory ectatic corneal disease characterized by changes in corneal collagen structure and organization. Though the etiology remains unknown, novel techniques...

Predictive Role of Molecular Subtypes in Response to Neoadjuvant Chemotherapy in Breast Cancer Patients

<strong>Background:</strong> Breast cancer is increasingly regarded as a heterogeneous disease which can be classified into distinct molecular subtypes with prognostic significance. <strong>Objectives:</strong> Retrospec...

The Efficacy of Transobturator Tape (TOT) in Treatment of Mixed Urinary Incontinence in Females

<strong>Background:</strong> mixed urinary incontinence (MUI) is defined as the complaint of involuntary loss of urine, associated with urgency and also with effort. Urodynamic studies (UDS) are widely considered the gol...

Download PDF file
  • EP ID EP503512
  • DOI -
  • Views 101
  • Downloads 0

How To Cite

(2017). The Future of Glaucoma Treatment Ripasudil. The Egyptian Journal of Hospital Medicine, 68(2), 1184-1188. https://europub.co.uk/articles/-A-503512